Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury

Taquet M. et al, (2023), Brain Communications, 6

Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study

Elneima O. et al, (2023), International Journal of Epidemiology

Long COVID research: an update from the PHOSP-COVID Scientific Summit

Brightling CE. et al, (2023), The Lancet Respiratory Medicine, 11, e93 - e94

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

Raman B. et al, (2023), The Lancet Respiratory Medicine, 11, 1003 - 1019

Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs.

Weeratunga P. et al, (2023), Nature communications, 14

Implementable Deep Learning for Multi‐sequence Proton MRI Lung Segmentation: A Multi‐center, Multi‐vendor, and Multi‐disease Study

Astley JR. et al, (2023), Journal of Magnetic Resonance Imaging, 58, 1030 - 1044

Neutrophil levels correlate with quantitative extent and progression of fibrosis in IPF: results of a single-centre cohort study.

Achaiah A. et al, (2023), BMJ open respiratory research, 10

A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2.

Wilkinson T. et al, (2023), ERJ open research, 9, 249 - 2023

Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.

Taquet M. et al, (2023), Nature medicine

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

Jackson C. et al, (2023), The Lancet Respiratory Medicine, 11, 673 - 684

Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis.

Dawson C. et al, (2023), BMJ open respiratory research, 10

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

Zheng B. et al, (2023), The Lancet Regional Health - Europe, 29, 100635 - 100635

Cohort Profile: Post-hospitalisation COVID-19 study (PHOSP-COVID)

Elneima O. et al, (2023)

Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post–COVID-19 Study

Stewart I. et al, (2023), American Journal of Respiratory and Critical Care Medicine, 207, 693 - 703

Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Absence in the Lungs of Fatal COVID-19: A Retrospective Histopathology Cohort Study

Melero I. et al, (2023), SSRN Electronic Journal

Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study

McAuley HJC. et al, (2023), eClinicalMedicine, 57, 101896 - 101896

Correction: The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium

Daynes E. et al, (2023), Trials, 24

Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

Khoo SH. et al, (2023), The Lancet Infectious Diseases, 23, 183 - 195

The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium

Daynes E. et al, (2023), Trials, 24

Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury

Cross AR. et al, (2023), JCI Insight, 8

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?